The Ministry of Food and Drug Safety in South Korea has approved the first depression diagnosis support AI software-as-a-medical device in the country.
Developed by local AI company Acryl, the product called ACRYL-D01 uses AI to analyse patient interviews to calculate their probability of having depression. It has also been designated as an innovative medical device.
Founded in 2011, Acryl...
